Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007 | Zendy

Danuta M. Skowronski | Zendy; Gaston De Serres | Zendy; Jim Dickinson | Zendy; Martin Petric | Zendy; Annie Mak | Zendy; Kevin Fonseca | Zendy; Trijntje L. Kwindt | Zendy; Tracy Chan | Zendy; Nathalie Bastien | Zendy; Hugues Charest | Zendy; Yan Li | Zendy

Open Access

Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007

Author(s) -

Danuta M. Skowronski,

Gaston De Serres,

Jim Dickinson,

Martin Petric,

Annie Mak,

Kevin Fonseca,

Trijntje L. Kwindt,

Tracy Chan,

Nathalie Bastien,

Hugues Charest,

Yan Li

Publication year - 2008

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/595862

Subject(s) - odds ratio , hemagglutination assay , virology , influenza like illness , medicine , influenza vaccine , influenza a virus , vaccination , biology , immunology , virus , titer

Trivalent inactivated influenza vaccine (TIV) is reformulated annually to contain representative strains of 2 influenza A subtypes (H1N1 and H3N2) and 1 B lineage (Yamagata or Victoria). We describe a sentinel surveillance approach to link influenza variant detection with component-specific vaccine effectiveness (VE) estimation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research